Yahoo Finance Today's Research Reports on Trending Tickers: Neurocrine Biosciences and Amarin
NEW YORK / ACCESSWIRE / November 14, 2018 / U.S. equities closed down on Wednesday as tech giant Apple closed near bear-market territory and another drop in oil prices raised concerns of a global economic slowdown. The Dow Jones Industrial Average dropped 0.81 percent to close at 25,080.50, while the S&P 500 Index shed 0.76 percent to close at 2,701.58. The Nasdaq Composite Index plunged 0.9 percent at 7,136.39.
According to Frank Cappelleri, executive director at Instinet, "The crude crash has gotten extreme, while a mean reverting move is expected soon, the downturn has had negative effects on both the high yield bond market and credit spreads — all of which will be influential on any rally attempts for equities."
MERInitiates Coverage on:
NeurocrineBiosciences, Inc.
https://marketedgereport.com/report/NBIX/
AmarinCorporation plc
https://marketedgereport.com/report/AMRN/
Neurocrine Biosciences' stock moved 13.44% lower Wednesday, to close the day at $86.13. The stock recorded a trading volume of 3,246,890 shares, which was above its three months average volume of 745,261 shares. In the last year, Neurocrine Biosciences' shares have traded in a range of 67.33 - 126.98. The share price has gained 27.92% from its 52 week low. The company's shares are currently trading below their 200-day moving average. The stock's 50-day moving average of $111.51 is above its 200-day moving average of $106.75. Shares of Neurocrine Biosciences have fallen roughly 22.74 percent in the past month and are up 11.01 percent year-to-date.
AccessMER's Neurocrine Biosciences, Inc. Research Report at:
https://marketedgereport.com/report/NBIX/
On Wednesday, shares of Amarin recorded a trading volume of 30,582,277 shares, which was above the three months average volume of 16,130,375 shares. The stock ended the day 4.81% higher at $16.12. The share price has fallen 30.93% from its 52 week high with a 52 week trading range of 2.35 - 23.34. The company's shares are currently trading above their 200-day moving average. The stock's 50-day moving average of $19.41 is above its 200-day moving average of $7.33. Shares of Amarin have fallen roughly 17.96 percent in the past month and are up 302 percent year-to-date.
AccessMER's Amarin Corporation plc Research Report at:
https://marketedgereport.com/report/AMRN/
Our Actionable Research on Neurocrine Biosciences, Inc. (NASDAQ:NBIX) and Amarin Corporation plc (NYSE:AMRN) can be downloaded free of charge at MarketEdge Report.
MarketEdge Report
We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.
MarketEdge has not been compensated; directly or indirectly; for producing or publishing this document.
Disclaimer: This article is written by an independent contributor of MarketEdgeReport.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. MarketEdgeReport.com is neither a registered broker dealer nor a registered investment advisor. For more information please read our full disclaimer at www.marketedgereport.com/disclaimer.
CONTACT
For any questions, inquiries, or comments reach out to us directly at:
Address:
MarketEdge Report, Unit #901 511 Avenue of the Americas, New York, NY, 10011
Email:
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE: MarketEdgeReport
